Pramana and ARUP Laboratories Collaborate on AI-Powered Pathology
Pramana, Inc. and ARUP Laboratories have announced a collaboration to digitize pathology slides and develop AI-powered algorithms to improve the assessment of bone marrow biopsies and other diagnostic challenges in hematopathology. This partnership combines ARUP's expertise in hematopathology with Pramana's SpectralHT autonomous whole-slide imaging scanners to enhance diagnostic precision and efficiency announced in a press release.
The AI model development will be led by ARUP, utilizing its expert hematopathologists and annotation tools to train and validate the algorithms using real-world clinical cases. These algorithms will be designed to run efficiently on Pramana's SpectralHT scanners, showcasing the viability of in-line edge computing for real-time AI diagnostics. The collaboration aims to commercialize these advanced diagnostic algorithms, ensuring they meet regulatory standards and drive broader industry adoption.
Pramana's SpectralHT scanners feature in-line Edge AI computing, allowing real-time quality control and automated image processing. This technology reduces the burden on lab personnel while ensuring high-quality data output, improving image quality and detail for challenging diagnostic slides such as those in hematopathology and cytology.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Oct 2 Avimer Bio and CNIO Detail AI Method for Protein Cage Design Oct 2 SPHERE HEALTH Opens Early Access to AI Hormonal Care Platform Oct 2 SAS and NC State Launch AI Research Partnership Oct 2 MontoHealth Develops AI Agents for Healthcare Administrative Work Oct 1 RFK Jr. says AI can give patients better medical second opinionsLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
ARPA-H Awards UpDoc Up to $9.2 Million for Clinical AI
Atman Health Wins ARPA-H Award to Build Heart Failure AI
Domino Data Lab and EPAM Partner on Validated AI for Life Sciences
NYU Langone Tests AI Tool to Fill Radiology Training Gaps
Hansa Biopharma Partners With Cradle on AI Protein Design
Daily AI Brief: the AI news that matters, in your inbox.